Dentalis Animal Health appoints Advisory Board
Dentalis Animal Health, a company specializing in Oral Health care for companion animals, has announced the appointment of its Advisory Board.
Michael Kelly
Michael Kelly is an Animal Health Pharmaceutical Industry veteran with broad international business experience. A graduate of Harvard Business School and Cornell University, Michael was hired by Ciba-Geigy to begin his post graduate career in Switzerland. Eventually ending up in the Novartis Animal Health US Division (following the Ciba-Sandoz merger) he rose to CFO and VP of North America. In 2009 Kelly joined Piedmont Animal Health (PAH), a drug development company, and served various roles including CFO, COO and President. During his tenure at PAH the organization received more FDA Companion Animal Drug approvals than any other Company in the Industry.
Dr Stephanie Livermore
Dr. Stephanie Livermore has been practicing companion animal medicine and surgery since her graduation from the University of Guelph in 2008. Dr. Livermore honed her skills in veterinary dentistry over the years. She is currently the Medical Director at Pearly Bites Veterinary in Manhattan, where she focuses exclusively on oral health care in companion animals.
Dr Faleh Tamimi
Dr. Faleh Tamimi is a professor in dentistry and a scientist. He has published over 180 peer reviewed scientific papers, one book and 4 book chapters. His research is mainly in the field of dentistry, dental materials, and tissue engineering. He has held academic appointments at McGill University (Montreal, Canada) and is currently Associate Dean of Academics at Qatar University. He has received numerous prestigious honors such as the Canada Research Chair.
Frank Rana
As a graduate of Concordia University. Frank spent the first six years of his career in public accounting before joining Dorel Industries in 1987. He has served as Senior Vice President of Finance since 2015. He is a member of the leadership team which drives the company’s growth strategy and has been an integral part of all business acquisitions since the Company’s initial public offering.
“We welcome Michael, Frank, Stephanie and Faleh to the team. This Advisory Board brings a wealth of Animal Health, dentistry and business experience to Dentalis,” says President Kevin McDonnell.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230203005342/en/
Contact information
David Hauptman
David@dentalis.ca
1-514-578-0345
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SecurityBridge Teams up With Microsoft to Enhance SAP Security With Microsoft Sentinel13.5.2025 10:17:00 EEST | Press release
SecurityBridge, the Cybersecurity Command Center for SAP, is pleased to announce its collaboration with Microsoft to integrate SAP data into Microsoft Sentinel. The integration enables SecurityBridge to seamlessly share SAP security events with Microsoft Sentinel’s cloud-native security information and event management (SIEM)—enhancing the visibility to detect and respond to threats across SAP landscapes when it matters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513088279/en/ SecurityBridge x Microsoft Sentinel in action. "This close collaboration represents a significant advancement in SAP security. Combining our SAP-native cybersecurity platform with Microsoft Sentinel’s capabilities makes complex SAP security events accessible and actionable for all security teams, ultimately supplying customers with the knowledge to better secure SAP systems from threats," said Ivan Mans, CTO & Co-Founder, SecurityBridge. SAP sys
Saildrone Closes $60M Financing to Bring Maritime Autonomy to Europe13.5.2025 10:05:00 EEST | Press release
Saildrone, the global leader in maritime autonomy, today announced the closing of a $60 million investment round led by EIFO, the Export and Investment Fund of Denmark. The investment will be used to bring Saildrone technology to Europe to address the urgent need for maritime security for critical infrastructure and wider defense applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513296505/en/ Four Saildrone Voyager uncrewed surface vehicles (USVs) will be deployed in Danish waters during the summer of 2025 in partnership with the Danish Armed Forces. The operational testing will begin in June and is part of a broader effort to integrate uncrewed systems into Denmark’s defense architecture. The Baltic, North Sea, and European Arctic waters are currently facing unprecedented threats, and the need for persistent maritime domain awareness has never been greater. Saildrone’s extreme endurance unmanned surface vehicl
New Mirakl-Storfund Partnership Offers Businesses Improved Cash Flow on 400+ Marketplaces13.5.2025 10:00:00 EEST | Press release
Storfund has announced a new partnership that will enable businesses to use the fintech’s cash flow solution on the 400+ marketplaces powered by Mirakl, the leading provider of ecommerce software solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513755226/en/ New Mirakl X Storfund partnership launches The solution, called Daily Advance, is the first financing product to be embedded on Mirakl Connect. Designed to eliminate the standard delay of 25 days between sale and payout, Daily Advance will see Storfund pay businesses as soon as they ship their goods, improving their cash flow and supporting their growth. The service will be available on marketplaces globally including Macy’s, Nordstrom, Best Buy, B&Q, Decathlon and Carrefour. The deal comes a few months after Storfund’s launch on TikTok Shop, a partnership which has already seen Storfund finance tens of millions in sales to US sellers. The new partnership wit
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 09:00:00 EEST | Press release
Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Penthouses, starting from USD 6 million, feature 180-degree vistas and expansive interiors, while Sky Mansions, starting from USD 21 million, offer 360-degree panoram
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 09:00:00 EEST | Press release
TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic relief only. There is a huge unmet need with a prevalence that has doubled in the last 25 years to an estimated 10 million sufferers, and it is expected to double again by 20501,2. Research into cell replacement strategies for Parkinson’s disease has been ongoing for decades and the promise of cell therapy in the disease has resulted in a dynamic cli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom